The DPP-4 inhibitor sitagliptin improves glycaemic control and early-stage diabetic nephropathy in adolescents with type 1 diabetes using the MiniMed 780G advanced hybrid closed-loop system: a randomised controlled trial
Elbarbary NS, Ismail EA, El-Hamamsy MH, et al.
Diabetologia. Pub. online 14 Sep 2024.
Leggi